Ingenito Gary's Form 4 filing
Catalyst Pharmaceuticals, Inc. (CPRX) · filed Nov 29, 2024
- Accession no.
- 0001161697-24-000492
- Filed
- Nov 29, 2024
- Trade date
- Nov 27, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $272.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ingenito GaryCIK 0001279473 | Officer (Chief Med. & Reg. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 27, 2024 | Common stock, par value $0.001 per share | MOption exerciseAcquired | +12,000 | $4.01 | +$48,120 | 63,391 | Direct | |
| Nov 27, 2024 | Common stock, par value $0.001 per share | SSaleDisposed | −8,631 | $22.74 | −$196,268.94 | 54,760 | Direct | |
| Nov 27, 2024 | Common stock, par value $0.001 per share | SSaleDisposed | −3,369 | $22.67 | −$76,375.23 | 51,391 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 27, 2024 | Common Stock | MOption exerciseDisposed | −12,000 | $0.00 | $0 | 1,041,631 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.